对比
2p21 Microdeletion Syndrome Without Cystinuria C4749458 vs 16p13 11 Microdeletion Syndrome C4304596
两者均为需支持治疗的罕见先天性染色体缺失。现有资料明确位点及严重程度标签不同，但详细症状、起病和结局尚未充分确立。
2p21 Microdeletion Syndrome Without Cystinuria C4749458
A chromosomal deletion on chromosome 2 involving some genes shared with another condition but without the kidney component. Supportive care addresses each person's specific needs.
16p13 11 Microdeletion Syndrome C4304596
A rare chromosomal deletion where a portion of chromosome 16 is missing. It may be associated with developmental delays, intellectual disability, and sometimes congenital anomalies. Management focuses on supportive care and addressing individual needs.
6 个对比维度
Onset
2p21 Microdeletion Syndrome Without Cystinuria C4749458
0-null
16p13 11 Microdeletion Syndrome C4304596
0-null
Onset patterns differ
Severity
2p21 Microdeletion Syndrome Without Cystinuria C4749458
severe
16p13 11 Microdeletion Syndrome C4304596
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome Without Cystinuria C4749458
Chronic
16p13 11 Microdeletion Syndrome C4304596
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome Without Cystinuria C4749458
No
16p13 11 Microdeletion Syndrome C4304596
No
Different transmission
Body System
2p21 Microdeletion Syndrome Without Cystinuria C4749458
congenital
16p13 11 Microdeletion Syndrome C4304596
congenital
Same/different system
Category
2p21 Microdeletion Syndrome Without Cystinuria C4749458
rare-disease
16p13 11 Microdeletion Syndrome C4304596
genetic
Different category
结论
2p21-microdeletion-syndrome-without-cystinuria-C4749458 and 16p13-11-microdeletion-syndrome-C4304596 differ in severity, etiology
关键鉴别要点
在床旁或检查过程中最能可靠区分两种疾病的发现。
| 特征 | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 16p13 11 Microdeletion Syndrome C4304596 | 鉴别力 |
|---|---|---|---|
| 染色体位点 | 涉及2p21的缺失，且无胱氨酸尿 | 涉及16p13.11的缺失 | High |
| 发育特征 | 具体发育表现在资料中未确立 | 可能有发育迟缓或智力障碍 | Moderate |
| 肾脏受累 | 按定义无胱氨酸尿或肾脏成分 | 资料未描述肾脏受累 | Moderate |
何时更支持某种疾病
选择 2p21 Microdeletion Syndrome Without Cystinuria C4749458 的情况
检测证实2p21缺失且无胱氨酸尿
位点及排除的肾脏成分符合该情况
High
需与伴胱氨酸尿的相关2p21缺失区分
无胱氨酸尿是所述诊断界限
Moderate
仅依据重度标签考虑诊断
严重程度本身不能确立诊断
Low
选择 16p13 11 Microdeletion Syndrome C4304596 的情况
检测证实16p13.11缺失
染色体位点可识别该综合征
High
因发育迟缓、智力障碍或畸形而检测
这些特征仅为可能表现，需基因确认
Moderate
仅使用中度严重程度标签
标签不能替代位点特异性检测
Low
关键检查差异
| 检查 | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 16p13 11 Microdeletion Syndrome C4304596 | 解读 |
|---|---|---|---|
| 染色体微阵列 | 涉及2p21的缺失 | 涉及16p13.11的缺失 | 位点可区分两者，需临床医生解读。 |
| 胱氨酸尿或肾脏评估 | 按定义无胱氨酸尿，无界值 | 预期结果未确立 | 未经临床指导检测，不应推断肾病。 |
| 发育评估 | 资料未确立具体结果 | 可能显示迟缓或智力障碍 | 评估指导支持需求，但不能替代基因诊断。 |
预后对比
2p21 Microdeletion Syndrome Without Cystinuria C4749458
- 转归
- 终身结局未确立；资料标注为重度且慢性。
- 因素
- 缺失范围、伴随表现和支持需求；确切预测因素未提供。
16p13 11 Microdeletion Syndrome C4304596
- 转归
- 结局未确立；可能有发育障碍，严重程度标注为中度慢性。
- 因素
- 缺失范围、发育、先天畸形及可用支持。
时间范围: 终身，但确切起病和病程未确立。
个体表型和支持治疗比分类标签更重要。
并发症对比
| 并发症 | 表现 |
|---|---|
| 胱氨酸尿或肾脏并发症 | 按病情定义不存在 资料未描述 一侧不存在并不能确定另一侧肾脏状态。 |
| 神经发育困难 | 具体并发症未确立 可能发生发育迟缓或智力障碍 可能性不应视为必然发生。 |
| 先天畸形 | 资料未确立 有时相关，但频率未提供 需个体化评估，尚无确定模式。 |
患者教育要点
- High基因确认
诊断取决于染色体位点，而非仅凭症状或严重程度标签。
- High支持治疗
治疗应个体化；此处未确立剂量或标准方案。
- Medium传播
两者均不具传染性。遗传问题需临床或遗传咨询。